The multinational, multicenter, prospective RESTORE Study is the 5-year follow-up study of the phase 3 clinical RESCUE and ...

The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the ...

Lana Rifkin, MD, a uveitis specialist at Ophthalmic Consultants of Boston, shared insights into her work and her role as ...

A study conducted on over 77,000 individuals found that alcohol consumption increased the risk of dry eye in women.

Enhanced monofocal IOLs provide a slight depth-of-focus boost without compromising contrast, making them a versatile choice ...

Alcon Laboratories recalled Lot 10101 of Systane Lubricant Eye Drops Ultra PF due to fungal contamination, posing potential ...

As 2024 comes to a close, we here at Ophthalmology Times and the greater Eye Care Network would like to thank you–the reader.

Artificial intelligence's potential in ophthalmology, particularly in ocular imaging, was a major focus, with debates on its ...

Electrical stimulation therapy is being explored as a potential treatment to enhance neuroplasticity and improve visual ...

The NYU Grossman School of Medicine launches a Journal Club series with Ophthalmology Times, featuring expert faculty ...

Alon Kahana, MD, PhD, discusses the role of interleukin-6 in thyroid eye disease and the potential of tourmaline Bio's IL-6 ...

A Helsinki University Hospital study found diabetes, glycemic control, or insulin therapy did not significantly affect ...